study d7 Flashcards
insulin
how it works
Insulin (reduces blood glucose levels)
* stimulates transport of glucose from blood to insuline-sensitive tissues (muscle, adipose tissue)
* increases glycogen synthesis
* increases triglyceride synthesis
* increases protein synthesis (anabolic hormone)
* inhibits gluconeogenesis
* inhibits lipolysis
Regular insulin as produced by our pancreas
The pancreas is always releasing a little bit of insulin the background to affect lipolysis for eg.
insulin
types, clinical use, adverse effects
- Intermediate and long duration forms have low solubility and gradually dissolve over longer periods of time (never injected i.v)
- short duration, fastest acting
- Short duration, slower acting,
- intermediate duration, slow acting
- Long duration, slowest acting
Clinical uses:
* treatment of type 1 and type 2 diabetes mellitus
* also used to treat hyperkalemia
Adverse effects:
* hypoglycemia
* tachycardia/palpitations, sweating and nervousness
* headache, confusion, drowsiness convulsions, coma
lipohypertrophy at injection site
sulfonylureas, biguanides, glitazones
antuhyperglycemic diabetes drugs
Sulfonylureas
gliclazide (Diamicron) glyburide (Diabeta) (p.o.)
promote insulin secretion by the pancreas
Biguanides
metformin (Glucophage) (p.o)
decreased production of glucose (liver)
increased uptake of glucose (muscles, adipose)
Glitazones
rosiglitazone (Avandia) (p.o.)
decreased insulin resistance
adverse effects: retention of fluid / heart failure
GLP1 agonist, DPP-4 inhibitors
Glucagon Like Peptide (GLP)-1 Receptor Agonists
* iraglutide (Victoza), semaglutide (s.c.)
* increase effect of endogenous incretin* (GLP-1),
* increases glucose-dependant release of insulin
side effects:
decreased appetite; risk of thyroid cancer
Dipeptidyl peptidase-4 (DPP-4) Inhibitors
Sitagliptin (Januvia), saxagliptin, linagliptin (p.o.)
* increases incretin (GIP, GLP-1) levels by inhibiting DPP-4,
an enzyme that normally inactivates the incretin hormones
* incretins then increase release of insulin
plasma lipid levels
- Lipoproteins regulate the transport of cholesterol and triglycerides
- Low Density Lipoproteins (LDLs) initiate and fuel the development of atherosclerosis.
- HDLs may assist in reduce cholesterol levels in atherosclerotic plaques.
All drugs discussed in this section:
* reduce LDL levels
* reduce triglycerides* (except for bile acid binding resins)
HMG-CoA reductase inhibitors + adverse effects
HMG-CoA reductase Inhibitors (statins)
atorvastatin, rosuvastatin and others
adverse effects:
gastro-intestinal disturbances
elevation of liver enzyme tests
can cause myopathies*
myalgia: muscle pain;
normal creatine kinase (CK) plasma levels
myositis (muscle inflammation): muscle pain + elevated CK
rhabdomyolysis:
elevated myoglobin (blood, urine)
cholesterol abrosption inhibitors and PCSK9 inhibitors
Cholesterol Absorption Inhibitor (ezetimibe)
* blocks absorption of cholesterol from intestine
PCSK9 Inhibitors (evolocumab, alirocumab)
* monoclonal antibodies that target PCSK9 (LDL receptor inactivators)
result = more LDL receptors = decreased circulating levels of LDL
adverse effects: injection site reactions, …
bile acid sequesterants
nonabsorbable resin that binds to bile acids (and other substances) in the GI tract and promote their excretion
body uses cholesterol to replace lost bile acids
adverse effects:
constipation (often administered with a laxative)
thyroid horomones
principal actions
synthetic preparation of thyroxine (T4),
inactive precursor of the active form = triiodothyronine (T3)
thyroid hormones have three principal actions:
1. stimulation of energy use,
2. stimulation of the heart and
3. promotion of growth and development
drugs for hyperthyroidism
Levothyroxine
used for the treatment of hypothyroidism
half-life = 7 days; 4-6 weeks before observing maximal effect
excessively high doses = symptoms of hyperthyroidism:
tachycardia, angina, tremor, nervousness, insomnia, hyperthermia, ↑ intestinal motility and sweating
other drugs used to treat hyperthyroidism
methimazole, propylthiouracil*
Inhibit activation of T4 to T3
adverse effects:
liver injury*, rash, arthralgia, hypothyroidism (at high doses), agranulocytosis (rare)